Cardiovascular Diseases

The Centre Hospitalier Epicura in Ath is conducting research in cardiovascular disease focused on acute ischemic stroke and high-risk transient ischemic attack. The studies are designed to evaluate whether new treatment approaches can better prevent recurrent stroke and improve protection after a recent cerebrovascular event.

  • Testing a new therapy to reduce the risk of ischemic stroke
  • Studying treatment options for people after a high-risk transient ischemic attack
  • Assessing whether prevention strategies can improve outcomes after stroke

This work reflects a strong interest in improving stroke prevention and supporting safer, more effective care for patients at risk of further vascular events.

Hemic and Lymphatic Diseases

Clinical research at this site also covers hemic and lymphatic diseases, with studies in multiple myeloma and diffuse large B-cell lymphoma. These trials are exploring new treatment combinations and comparing them with established options to improve disease control and patient outcomes.

  • Evaluating new therapies for relapsed or refractory multiple myeloma
  • Comparing treatment approaches in newly diagnosed multiple myeloma
  • Testing improved options for relapsed or refractory diffuse large B-cell lymphoma

The research aims to find more effective and better-tolerated treatments for challenging blood cancers, with attention to both response and overall treatment benefit.

Neoplasms

In the field of neoplasms, the site is studying locally advanced rectal cancer and related cancer treatment strategies. The trials are assessing how different pre-surgical and combined treatment approaches may improve the balance between effectiveness and safety, especially in older patients.

  • Comparing treatment strategies for locally advanced rectal cancer
  • Evaluating approaches that may improve the trade-off between cancer control and safety
  • Supporting better treatment planning before surgery

These studies aim to refine rectal cancer care by identifying options that may offer strong results while reducing treatment burden.

Kidney Disease Research

Although the main therapeutic categories are broader, the trial portfolio at Centre Hospitalier Epicura also includes chronic kidney disease. This research is focused on improving kidney-related outcomes by examining whether new treatment options can lower urine albumin and better support standard care.

  • Studying a new therapy for chronic kidney disease
  • Measuring changes linked to kidney damage and disease progression
  • Evaluating whether treatment can improve renal protection alongside standard care

The goal is to advance kidney disease management through therapies that may help preserve kidney function and reduce long-term risk.